← Back
$TNGX All transactions

Tango Therapeutics, Inc.

▼ SELL

$ Value

$609K

Shares

86,459

Price

$7

Filed

Sep 9

Insider

Name

Third Rock Ventures IV, L.P.

Title

CIK

0001688327

Roles

10% Owner

Transaction Details

Transaction Date

2025-09-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,727,516

Footnotes

These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Filing Info

Accession No.

0001193125-25-199177

Form Type

4

Issuer CIK

0001819133

Third Rock Ventures IV, L.P.'s History

Date Ticker Type Value
2025-11-04 MAZE J
2025-10-23 TNGX $4.8M
2025-09-25 TNGX $4.0M
2025-09-16 TNGX $2.6M
2025-09-08 TNGX $609K
2025-09-05 TNGX $4.5M
2025-08-22 TNGX $2.1M
2025-08-19 TNGX $7.7M

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15